KJZZ is a service of Rio Salado College,
and Maricopa Community Colleges

Copyright © 2024 KJZZ/Rio Salado College/MCCCD
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Lawmakers move to expand access to MDMA, psilocybin mushrooms as medications

State lawmakers have advanced measures that could expand access to psilocybin drugs and MDMA in treating certain disorders.

One bill would fund a $30 million research program to study psilocybin mushrooms in treating post-traumatic stress disorder and depression.

Another would allow MDMA, also known as ecstasy, to be used as a prescription medication if the federal government removes its Schedule 1 drug status.

Both drugs have been unable to receive federal funding for research due to their Schedule 1 classification. 

The measures require full House approval, but have received bipartisan support in committees.

Greg Hahne started as a news intern at KJZZ in 2020 and returned as a field correspondent in 2021. He learned his love for radio by joining Arizona State University's Blaze Radio, where he worked on the production team.